Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Federal Trade Commission
Mallinckrodt
Moodys
Chubb
McKinsey
AstraZeneca
Baxter
UBS

Generated: January 17, 2018

DrugPatentWatch Database Preview

OXALIPLATIN Drug Profile

« Back to Dashboard

Which patents cover Oxaliplatin, and what generic alternatives are available?

Oxaliplatin is a drug marketed by Accord Hlthcare, Actavis Totowa, Cipla Ltd, Fresenius Kabi Oncol, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira Inc, Hospira Worldwide, Jiangsu Hengrui Med, Luitpold Pharms Inc, Mylan Labs Ltd, Qilu Pharm Co Ltd, Sandoz, Sandoz Inc, Sanja Pharms Co, Sun Pharma Global, and Teva Pharms. and is included in twenty-four NDAs.

The generic ingredient in OXALIPLATIN is oxaliplatin. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. There are six tentative approvals for this compound. Additional details are available on the oxaliplatin profile page.
Drug patent expirations by year for OXALIPLATIN
Pharmacology for OXALIPLATIN

US Patents and Regulatory Information for OXALIPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 090849-001 Apr 28, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 091358-002 Aug 7, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 202922-001 Apr 8, 2014 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 078812-002 Aug 7, 2009 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 078818-002 Aug 7, 2009 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold Pharms Inc OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 204378-001 May 12, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 200979-002 Aug 8, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold Pharms Inc OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 204378-002 May 12, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 207474-001 Mar 21, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gland Pharma Ltd OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 207385-001 May 23, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Novartis
Cantor Fitzgerald
McKesson
Chinese Patent Office
AstraZeneca
US Department of Justice
Citi
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot